Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4515620
Max Phase: Preclinical
Molecular Formula: C46H64N4O2
Molecular Weight: 705.04
Molecule Type: Unknown
Associated Items:
ID: ALA4515620
Max Phase: Preclinical
Molecular Formula: C46H64N4O2
Molecular Weight: 705.04
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CNC(=O)c3ncn(C)c3C(=O)NC[C@]3(C)CCC[C@]4(C)c5ccc(C(C)C)cc5CC[C@@H]34)CCC[C@]21C
Standard InChI: InChI=1S/C46H64N4O2/c1-29(2)31-12-16-35-33(24-31)14-18-37-43(5,20-10-22-45(35,37)7)26-47-41(51)39-40(50(9)28-49-39)42(52)48-27-44(6)21-11-23-46(8)36-17-13-32(30(3)4)25-34(36)15-19-38(44)46/h12-13,16-17,24-25,28-30,37-38H,10-11,14-15,18-23,26-27H2,1-9H3,(H,47,51)(H,48,52)/t37-,38-,43-,44-,45+,46+/m0/s1
Standard InChI Key: IASVMPXJQUOUEV-FGFPVNBJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 705.04 | Molecular Weight (Monoisotopic): 704.5029 | AlogP: 9.55 | #Rotatable Bonds: 8 |
Polar Surface Area: 76.02 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.28 | CX Basic pKa: 1.86 | CX LogP: 10.12 | CX LogD: 10.12 |
Aromatic Rings: 3 | Heavy Atoms: 52 | QED Weighted: 0.25 | Np Likeness Score: 0.30 |
1. Zhao F, Lu W, Su F, Xu L, Jiang D, Sun X, Shi J, Zhou M, Lin F, Cao F.. (2018) Synthesis and potential antineoplastic activity of dehydroabietylamine imidazole derivatives., 9 (12): [PMID:30746067] [10.1039/C8MD00487K] |
Source(1):